Assessing the cardiovascular safety of diabetes therapies.
Goldfine
Allison B
AB
Section on Clinical Research, Joslin Diabetes Center and Harvard Medical School, Boston, USA.
D026683:Advisory Committees; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D017277:Drug Approval / Q000379:methods*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D011358:Product Surveillance, Postmarketing; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
D007004:Hypoglycemic Agents